These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12747671)

  • 1. Bioresorbable polymeric stents: current status and future promise.
    Eberhart RC; Su SH; Nguyen KT; Zilberman M; Tang L; Nelson KD; Frenkel P
    J Biomater Sci Polym Ed; 2003; 14(4):299-312. PubMed ID: 12747671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting bioresorbable stents for various applications.
    Zilberman M; Eberhart RC
    Annu Rev Biomed Eng; 2006; 8():153-80. PubMed ID: 16834554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promise and challenges of bioabsorbable stents.
    Waksman R
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):407-14. PubMed ID: 17722019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioresorbable vascular scaffolds: Biodegradation, drug delivery and vascular remodeling.
    Tesfamariam B
    Pharmacol Res; 2016 May; 107():163-171. PubMed ID: 27001225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of biodegradable stents.
    Tanguay JF; Zidar JP; Phillips HR; Stack RS
    Cardiol Clin; 1994 Nov; 12(4):699-713. PubMed ID: 7850839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravascular bioresorbable polymeric stents: a potential alternative to current drug eluting metal stents.
    Sharkawi T; Cornhill F; Lafont A; Sabaria P; Vert M
    J Pharm Sci; 2007 Nov; 96(11):2829-37. PubMed ID: 17979210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the SYNERGY bioresorbable polymer metallic coronary stent.
    Shreenivas SS; Kereiakes DJ
    Future Cardiol; 2018 Jul; 14(4):307-317. PubMed ID: 29926758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of everolimus-eluting stent with a bioresorbable polymer coating for treatment of recurrent in-stent restenosis.
    Honda H; Meguro T; Takizawa K; Isoyama S
    J Invasive Cardiol; 2005 Feb; 17(2):112-5. PubMed ID: 15687539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts on cardiovascular stent devices.
    Neamtu I; Chiriac AP; Diaconu A; Nita LE; Balan V; Nistor MT
    Mini Rev Med Chem; 2014; 14(6):505-36. PubMed ID: 24873819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expandable bioresorbable endovascular stent. I. Fabrication and properties.
    Su SH; Chao RY; Landau CL; Nelson KD; Timmons RB; Meidell RS; Eberhart RC
    Ann Biomed Eng; 2003 Jun; 31(6):667-77. PubMed ID: 12797616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.
    Kandzari DE; Mauri L; Koolen JJ; Massaro JM; Doros G; Garcia-Garcia HM; Bennett J; Roguin A; Gharib EG; Cutlip DE; Waksman R;
    Lancet; 2017 Oct; 390(10105):1843-1852. PubMed ID: 28851504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The next generation of drug-eluting stents: what's on the horizon?
    Ramcharitar S; Vaina S; Serruys PW
    Am J Cardiovasc Drugs; 2007; 7(2):81-93. PubMed ID: 17503880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Absorbable coronary stents. New promising technology].
    Erbel R; Böse D; Haude M; Kordish I; Churzidze S; Malyar N; Konorza T; Sack S
    Herz; 2007 Jun; 32(4):308-19. PubMed ID: 17607538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives.
    Kitabata H; Waksman R; Warnack B
    Cardiovasc Revasc Med; 2014 Mar; 15(2):109-16. PubMed ID: 24684760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioresorbable scaffolds for the SFA: new developments.
    Werner M
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):455-9. PubMed ID: 24866776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in treatment by percutaneous coronary intervention: the stent of the future.
    Muramatsu T; Onuma Y; Zhang YJ; Bourantas CV; Kharlamov A; Diletti R; Farooq V; Gogas BD; Garg S; García-García HM; Ozaki Y; Serruys PW
    Rev Esp Cardiol (Engl Ed); 2013 Jun; 66(6):483-96. PubMed ID: 24776051
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.